Publications

1. Ji MF, He YQ, Tang MZ, Xue WQ, Yu X, Diao H, et al. (2025). Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China. Nat Commun. 16(1):5940. https://doi.org/10.1038/s41467-025-60999-5 PMID:40592923
2. Walters M, Barr R, Breda J, Celletti F, de Bragança J, Huybrechts I, et al. (2025). Non-communicable diseases in children: systems-based approaches to incorporating nutrition into medical care. Children (Basel). 12(11):1503. https://doi.org/10.3390/children12111503 PMID:41300620
3. Kozlakidis Z, Muradyan A, Sargsyan K, editors (2024). Digitalization of medicine in low- and middle-income countries: paradigm changes in healthcare and biomedical research. Sustainable Development Goals Series. Cham, Switzerland: Springer. https://link.springer.com/book/10.1007/978-3-031-62332-5
4. Yang R, Kwan W, Du Y, Yan R, Zang L, Li C, et al. (2024). Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids. Cancer Lett. 598:217106. https://doi.org/10.1016/j.canlet.2024.217106 PMID:38992487
5. Aisyah DN, Setiawan AH, Lokopessy AF, Faradiba N, Setiaji S, Manikam L, et al. (2024). The information and communication technology maturity assessment at primary health care services across 9 provinces in Indonesia: evaluation study. JMIR Med Inform. 12:e55959. https://doi.org/10.2196/55959 PMID:39037345
6. Liu N-N, Yi C-X, Wei L-Q, Zhou J-A, Jiang T, Hu C-C, et al. (2023). The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells. Cancer Cell. 41(11):1927–1944.e9. https://doi.org/10.1016/j.ccell.2023.08.012 PMID:37738973
7. AlKnawy B, Kozlakidis Z, Tarkoma S, Bates D, Honkela A, Crooks G, et al. (2023). Digital public health leadership in the global fight for health security. BMJ Glob Health. 8(2):e011454. https://doi.org/10.1136/bmjgh-2022-011454 PMID:36792230
8. Kozlakidis Z (2023). The incidence of Coronavirus disease 2019 (COVID-19) among vaccinated healthcare workers (HCWs): evidence for protection from hospitalisation from an Indonesian cohort. Lancet Reg Health Southeast Asia. 100146:100146. https://doi.org/10.1016/j.lansea.2023.100146 PMID:36643852
9. Bogaert B, Buisson V, Kozlakidis Z, Saintigny P (2022). Organisation of cancer care in troubling times: a scoping review of expert guidelines and their implementation during the COVID-19 pandemic. Crit Rev Oncol Hematol. 173:103656. https://doi.org/10.1016/j.critrevonc.2022.103656 PMID:35337970
10. He YQ, Wang TM, Ji M, Mai ZM, Tang M, Wang R, et al. (2022). A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening. Nat Commun. 13(1):1966. https://doi.org/10.1038/s41467-022-29570-4 PMID:35414057
11. Casati S, Ellul B, Mayrhofer MT, Lavitrano M, Caboux E, Kozlakidis Z (2022). Paediatric biobanking for health: the ethical, legal, and societal landscape. Front Public Health. 10:917615. https://doi.org/10.3389/fpubh.2022.917615 PMID:36238242
12. Kozlakidis Z (2022). Evidence for recombination as an evolutionary mechanism in coronaviruses: is SARS-CoV-2 an exception? Front Public Health. 10:859900. https://doi.org/10.3389/fpubh.2022.859900 PMID:35372203
13. Liu NN, Jiao N, Tan JC, Wang Z, Wu D, Wang AJ, et al. (2022). Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts. Nat Microbiol. 7(2):238–50. https://doi.org/10.1038/s41564-021-01030-7 PMID:35087227
14. Ngwa W, Addai BW, Adewole I, Ainsworth V, Alaro J, Alatise OI, et al. (2022). Cancer in sub-Saharan Africa: a Lancet Oncology Commission. Lancet Oncol. 23(6):e251–312. https://doi.org/10.1016/S1470-2045(21)00720-8 PMID:35550267
15. Al Knawy B, McKillop MM, Abduljawad J, Tarkoma S, Adil M, Schaper L, et al. (2022). Successfully implementing digital health to ensure future global health security during pandemics: a consensus statement. JAMA Netw Open. 5(2):e220214. https://doi.org/10.1001/jamanetworkopen.2022.0214 PMID:35195701
16. Stejskal L, Kalemera MD, Lewis CB, Palor M, Walker L, Daviter T, et al. (2022). An entropic safety catch controls hepatitis C virus entry and antibody resistance. Elife. 11:e71854. https://doi.org/10.7554/eLife.71854 PMID:35796426
17. Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z (2021). Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 19(3):171–83. https://doi.org/10.1038/s41579-020-00461-z PMID:33057203
18. Aisyah DN, Mayadewi CA, Diva H, Kozlakidis Z, Siswanto, Adisasmito W (2020). A spatial-temporal description of the SARS-CoV-2 infections in Indonesia during the first six months of outbreak. PLoS One. 15(12):e0243703. https://doi.org/10.1371/journal.pone.0243703 PMID:33351801
19. Kozlakidis Z, Abduljawad J, Al Khathaami AM, Schaper L, Stelling J (2020). Global health and data-driven policies for emergency responses to infectious disease outbreaks. Lancet Glob Health. 8(11):e1361–3. https://doi.org/10.1016/S2214-109X(20)30361-2 PMID:32791118
20. Vandenberg O, Durand G, Hallin M, Diefenbach A, Gant V, Murray P, et al. (2020). Consolidation of clinical microbiology laboratories and introduction of transformative technologies. Clin Microbiol Rev. 33(2):e00057–00019. https://doi.org/10.1128/CMR.00057-19 PMID:32102900